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Abstract ISG15 is an interferon-stimulated, linear di-ubiquitin-like protein, with anti-viral activity.
The role of ISG15 during bacterial infection remains elusive. We show that ISG15 expression in
nonphagocytic cells is dramatically induced upon Listeria infection. Surprisingly this induction can be
type I interferon independent and depends on the cytosolic surveillance pathway, which senses
bacterial DNA and signals through STING, TBK1, IRF3 and IRF7. Most importantly, we observed that
ISG15 expression restricts Listeria infection in vitro and in vivo. We made use of stable isotope
labeling in tissue culture (SILAC) to identify ISGylated proteins that could be responsible for the
protective effect. Strikingly, infection or overexpression of ISG15 leads to ISGylation of ER and Golgi
proteins, which correlates with increased secretion of cytokines known to counteract infection.
Together, our data reveal a previously uncharacterized ISG15-dependent restriction of Listeria
infection, reinforcing the view that ISG15 is a key component of the innate immune response.
DOI: 10.7554/eLife.06848.001
Introduction
Listeria monocytogenes is a food-borne pathogen that can cause enteric infections. In addition, in
immunocompromised individuals it can cross the blood–brain barrier and in pregnant women the
feto-placental barrier potentially leading to cases of meningitis and septicemia. To be fully virulent,
Listeria must evade macrophage killing, enter and replicate in epithelial cells and spread from cell to
cell. Towards these aims Listeria subverts a number of normal host cell functions in order to promote
its own replication and dissemination through a plethora of well-characterized virulence factors
(Cossart and Lebreton, 2014). Conversely, Listeria induces a rapid and sterilizing CD8+ T cell-
mediated adaptive immune response that has been extensively characterized (Lara-Tejero and
Pamer, 2004; Pamer, 2004). A more recent area of investigation has been the innate immune
response to the pathogen (Stavru et al., 2011).
Since Listeria is able to survive and replicate in the cytosol, several groups have sought to elucidate
how bacteria are sensed within macrophages and more recently within nonphagocytic cells. Once
Listeria has escaped from the phagosome, its multidrug efflux pumps secrete small molecules leading
to activation of an IRF3-dependent cytosolic surveillance pathway (CSP), resulting in type I interferon
activation (Crimmins et al., 2008). One of these small molecules, cyclic-di-AMP, is sufficient to
activate interferon β production in macrophages (Woodward et al., 2010). In nonphagocytic cells,
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type I interferon induction seems to emanate from sensing of triphosphorylated RNA molecules via
a RIG-I and MAVS-dependent pathway (Abdullah et al., 2012; Hagmann et al., 2013). Type I
interferon production subsequently leads to autocrine or paracrine activation of interferon-stimulated
genes (ISGs). We have recently shown that Listeria also activates the type III interferon pathway
(Lebreton et al., 2011; Bierne et al., 2012), a pathway which was discovered much later than type I
interferon (Kotenko et al., 2003; Sheppard et al., 2003). The type III interferon receptor has a more
limited tissue expression pattern than the receptor for type I interferon but activates a signaling
pathway similar to that of the type I interferon receptor. Several laboratories including ours have
recently contributed to the understanding of the type III interferon-dependent response to
intracellular viral and bacterial infections. Strikingly, the type III response occurs via peroxisomal
MAVS (Dixit et al., 2010; Odendall et al., 2014).
The role of one particular ISG, ISG15, during bacterial infection remains elusive. ISG15 is a linear
di-ubiquitin-like molecule (ubl) that is conserved from zebrafish to human; however, it is much less well
characterized than other ubls (Bogunovic et al., 2013). It can conjugate to over 300 cellular proteins and
can also function as a cytokine to induce interferon-γ production in peripheral blood mononuclear cells
(D’Cunha et al., 1996; Giannakopoulos et al., 2005; Zhao et al., 2005). Since Listeria, as other
pathogenic bacteria, often targets post-translational modifications during infection (Bonazzi et al., 2008;
Ribet and Cossart, 2010; Ribet et al., 2010), we were interested in investigating the interplay between
the interferon-stimulated ubl ISG15 and Listeria. ISG15 plays an important role in the innate immune
response to viruses. Isg15 expression becomes rapidly upregulated, and the protein is subsequently
conjugated to cellular and/or viral targets following type I interferon induction (Zhang and Zhang, 2011).
Mice deficient in ISG15 are susceptible to infection with Influenza, Sindbis, and Herpes viruses (D’Cunha
et al., 1996; Lenschow et al., 2005, 2007). Furthermore, many viruses encode proteins that specifically
impair ISGylation (Frias-Staheli et al., 2007). ISG15 seems to be unique among ubls, as it can both modify
specific target proteins and non-specifically modify proteins cotranslationally (Frias-Staheli et al., 2007;
Durfee et al., 2010; Zhao et al., 2010). Since ISG15 is strongly induced by type I interferon, which is
produced during bacterial infection, we aimed to decipher whether ISG15 is induced during Listeria
infection and if so whether ISGylation acts as a means of host defense against invading bacteria.
Here, we show that in nonphagocytic cells ISG15 is dramatically induced upon Listeria infection and
that, surprisingly, early induction can be type I interferon independent. Listeria-mediated ISG15
induction depends on the CSP, which senses bacterial DNA and signals through STING, TBK1, IRF3,
and IRF7. Most importantly, we demonstrate that ISG15 counteracts Listeria infection both in vitro and
eLife digest Listeria monocytogenes is a bacterium that can cause serious food poisoning in
humans. Infections with this bacterium can be particularly dangerous to young children, pregnant
women, the elderly, and individuals with weakened immune systems because they are more
susceptible to developing serious complications that can sometimes lead to death.
The bacteria infect cells in the lining of the human gut. Cells that detect the bacteria respond by
producing proteins called interferons and other signaling proteins that activate the body’s immune
system to fight the infection. One of the genes that the interferons activate encodes a protein called
ISG15, which helps to defend the body against viruses. However, it is not clear what role ISG15 plays
in fighting bacterial infections.
Here, Radoshevich et al. studied the role of ISG15 in human cells exposed to L. monocytogenes.
The experiments show that ISG15 levels increase in the cells, but that the initial increase does not
depend on Interferon proteins. Instead, ISG15 production is triggered by an alternative pathway
called the cytosolic surveillance pathway, which is activated by the presence of bacterial DNA inside
the cell.
Further experiments found that ISG15 can counteract the infections of L. monocytogenes both in
cells grown in cultures and in living mice. ISG15 modifies other proteins in the cell to promote the
release of proteins called cytokines that help the body to eliminate the bacteria. Radoshevich et al.’s
findings reveal a new role for ISG15 in fighting bacterial infections. A future challenge will be to
understand the molecular details of how ISG15 triggers the release of cytokines.
DOI: 10.7554/eLife.06848.002
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in vivo. We identified protein targets of ISGylation following overexpression of ISG15 using stable
isotope labeling in tissue culture (SILAC) analysis and uncovered a prominent enrichment in integral
membrane proteins of the endoplasmic reticulum and Golgi apparatus. This enrichment correlated
with an increase in canonical secretion of cytokines known to control infection, highlighting a new
mechanism of regulation of the host response to an intracytosolic pathogen.
Results
ISG15 is induced by L. monocytogenes infection both in vitro and in vivo
To test whether ISG15 and ISGylation are induced upon bacterial infection, we infected HeLa cells
with Listeria. Upon L. monocytogenes infection, ISG15 was massively induced, whereas incubation
with the related non-pathogenic bacterium, Listeria innocua, did not lead to an increase in ISG15
production (Figure 1A). We subsequently monitored ISG15 expression in cells infected with Listeria
over time. ISG15 protein levels increased relatively rapidly; the unconjugated protein was already
present at 6 hr post infection and accumulated steadily throughout the infection (Figure 1B). We next
investigated whether ISG15 induction following Listeria infection also occurs in vivo. After 72 hr of
systemic sub-lethal Listeria infection in mice, there was a robust induction of ISG15 and ISGylated
conjugates in infected liver tissue, revealing that Listeria infection leads to ISG15 induction both in
vitro and in vivo (Figure 1C).
ISG15 induction can be type I interferon independent
Since ISG15 protein levels increased relatively rapidly and ISG15 is known to be transcriptionally
induced in response to interferon, we monitored transcript levels of both ISG15 and IFNB1 by
quantitative real time PCR (qRT-PCR). Interestingly, we found that the two transcripts are
concomitantly induced after 3 hr of infection with Listeria (Figure 1D,E). This concomitant induction
led us to hypothesize that ISG15 could be induced in an interferon-independent manner during
Listeria infection. In order to test this hypothesis, we used the viral protein B18R to block signaling
from the interferon receptor (Chairatvit et al., 2012). The protein acts similarly to a blocking
antibody. When cells are pretreated with B18R, the viral protein inhibits binding of interferon to its
receptor, which is thus prevented from signaling. Following pretreatment with B18R, HeLa cells were
either stimulated with interferon or infected with Listeria to assess whether the bacterial-ISG15
induction was dependent on secreted interferon signaling in an autocrine or paracrine manner. We
observed that bacteria-induced ISG15 production was not diminished by B18R pretreatment in stark
contrast to the interferon-induced ISG15 signal, which was almost entirely abrogated by B18R
pretreatment (Figure 1F). To confirm the B18R results, we took advantage of a human fibrosarcoma
cell line, 2fTGH, from which interferon-unresponsive mutants have been isolated (Pellegrini et al.,
1989). The U5A clone lacks a functional IFNAR2 receptor (IFNAR2−/−) and thus is impaired in type I
interferon receptor signaling (Lutfalla et al., 1995). 2fTGH and U5A cells were both highly permissive
to Listeria infection (Figure 1—figure supplement 1). Strikingly in the U5A cells (defective for type I
interferon binding and signaling), as in 2fTGH cells, there is still a robust ISG15 response to Listeria
infection (Figure 1G).
Since B18R treatment does not inhibit type III interferon signaling, ISG15 induction could arise via
type III interferon receptor activation (Bandi et al., 2010). However, 2fTGH cells are unresponsive to
type III interferon (Zhou et al., 2007). Therefore, the ISG15 protein induction that we observed is
independent of both type I and type III interferon signaling. Taken together, our results show that
ISG15 can be induced by Listeria in an interferon-independent manner in human nonphagocytic cells.
We thus sought to determine how ISG15 was induced and what consequences ISG15 expression had
on the cell and on infection.
Cytosolic Listeria induces ISG15
To determine which signaling pathway was responsible for the Listeria-induced ISG15 transcript and
to help identify the cellular compartment in which bacteria are sensed, we made use of Listeria strains
that are impaired at different stages of infection. Incubation of cells with L. innocua, a non-pathogenic
Listeria species which cannot invade cells, did not induce ISG15 induction, demonstrating that
external pathogen recognition receptors were not involved (Figure 2A). We then used a strain of
Radoshevich et al. eLife 2015;4:e06848. DOI: 10.7554/eLife.06848 3 of 23
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Figure 1. ISG15 is induced by Listeria monocytogenes infection both in vitro and in vivo and ISG15 induction can be
type I interferon independent. (A) HeLa cells were lysed and immunoblotted with α-ISG15, α-EF-Tu (EF-Tu is
a prokaryotic translation elongation factor that we use as an indicator of infection level), and α-ACTIN following 12 or
24 hr of interferon β treatment at 1000 units/ml, infection with L. monocytogenes for 18 hr at multiplicity of infection
(MOI) of 10 or 25 bacteria per human cell, and incubation with Listeria innocua at MOI of 10 or 25 bacteria per human
cell. (B) HeLa cells were lysed and immunoblotted with α-ISG15, α-EF-Tu, and α-ACTIN following a time course of
L. monocytogenes infection from 3 to 24 hr, interferon β treatment for 24 hr was used as a positive control for
ISGylation. (C) Liver tissue from mice injected with saline or infected with Listeria for 72 hr was lysed and
immunoblotted with α-ISG15, each lane corresponds to a distinct animal (* indicates background band). (D) Relative
fold change by qRT-PCR of ISG15 transcript following time course of infection with Listeria. (E) Relative fold change
of ISG15 by qRT-PCR compared with the interferon β transcript over time course of infection with Listeria; data
represented in a logarithmic scale. (F) Cells were lysed and immunoblotted with α-ISG15 and α-ACTIN following pre-
treatment with the viral protein B18R followed by interferon α2 treatment (1000 μ/ml) or Listeria infection. (G) 2fTGH
and U5A (IFNAR2−/−) cells were lysed and immunoblotted with α-ISG15 and α-ACTIN following Listeria infection for
18 hr.
DOI: 10.7554/eLife.06848.003
The following figure supplement is available for figure 1:
Figure supplement 1. 2fTGH cells are permissive to L. monocytogenes infection.
DOI: 10.7554/eLife.06848.004
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Figure 2. Listeria induces ISG15 via the cytosolic surveillance pathway (CSP) which senses bacterial DNA. (A) Cells were lysed and immunoblotted with the
indicated antibodies following infection with various mutants of Listeria: Listeria strain EGD (MOI 10), Δhly (MOI 10), ΔactA (MOI of 50), and L. innocua +
InlB (MOI of 100). Different MOIs were used at the outset in an attempt to equalize Colony forming units (CFUs) at the end of the experiment. CFUs per ml
of intracellular bacteria following infection were determined by serial dilution after 18 hr of infection. (B) As before cells were lysed and immunoblotted
with the indicated antibodies following infection with Listeria strain EGD-e PrfA* (MOI 10), ΔplcA (MOI 10), Δhly (MOI of 10), and a triple mutant of
ΔhlyΔplcAΔplcB (MOI of 100). CFUs per ml of intracellular bacteria following infection were determined by serial dilution after 24 hr of infection. (C) HeLa
cells were treated with siRNA pools targeting the indicated mRNA or siControl for 72 hr. Cells were then infected for 18 hr (MOI 10), lysed, and
immunoblotted with α-ISG15 and α-ACTIN antibodies. Values were generated using ImageJ to quantify relative levels of induction of ISG15 compared to
ACTIN. Values from three independent experiments are displayed (average ± SEM). siRNA knockdown was confirmed with qRT-PCR from a well of
a technical replicate. Statistical significance calculated using ANOVA followed by Bonferonni’s multiple comparison test against siControl. (D) Cells were
lysed and immunoblotted with α-ISG15 and α-ACTIN following permeablization without Cyclic-diAMP, with 1 μM Cyclic-diAMP or with 10 μM Cyclic-
diAMP. Average ± SEM; fold change of ISG15 or interferon β normalized to GAPDH levels following permeablization without Cyclic-diAMP, with 1 μM
Cyclic-diAMP or with 10 μMCyclic-diAMP. (E) Cells were lysed and immunoblotted with α-ISG15 and α-ACTIN following transfection with 800 ng of Listeria
genomic DNA, Listeria genomic DNA treated with DNAase or total Listeria RNA for 24 hr; Average ± SEM; values were generated using ImageJ to
quantify relative levels of induction of ISG15 compared to ACTIN in three independent experiments. Statistical significance calculated using ANOVA
Figure 2. continued on next page
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L. innocua that expresses Internalin B (InlB), a L. monocytogenes virulence factor that mediates entry
into nonphagocytic cells (Dramsi et al., 1995). These bacteria enter the cell and are entrapped in
a membrane-bound phagosome, but lack the required virulence factors to escape from it. This strain
was also unable to induce an ISG15 signal, suggesting that the pathogen recognition receptors that
survey the phagosome are not sufficient for ISG15 induction (Figure 2A). Listeria’s hemolysin,
listeriolysin O (LLO) is an extremely potent virulence factor, which triggers vacuolar escape of the
bacterium as well as a plethora of changes in the host cell (Hamon et al., 2012). Strikingly, we found
that the Δhly mutant was able to potently induce ISG15 (Figure 2A). Thus, LLO is not necessary for
ISG15 induction. However, in several human epithelial cell lines the mutant that lacks LLO (Δhly) can
still escape into the cytosol (Portnoy et al., 1988; Marquis et al., 1995). Listeria expresses two
phospholipases that can compensate for the lack of LLO in the Δhly mutant in order to free the
bacterium from the phagosome in human epithelial cells (Marquis et al., 1995; Smith et al., 1995).
To assess whether Listeria trapped in the phagosome could induce ISG15, we constructed a triple
mutant (lacking LLO, PLCA, and PLCB) of Listeria. This mutant is unable to escape the phagosome of
human epithelial cells (Figure 2—figure supplement 1). Single mutants (either in PLCA or LLO), which
escape into the cytosol, induce a strong ISG15 signal relative to non-infected cells (Figure 2B). In
contrast, the triple mutant that is confined to the phagosome does not induce ISG15 (Figure 2B). We
thus conclude that only cytoplasmic bacteria induce ISG15. In fact, the only other mutant to induce
less ISG15 production was the ΔactA mutant (Figure 2A). This mutant is unable to spread from cell to
cell and cannot escape autophagic recognition, degradation, and lysis (Gouin et al., 2005; Yoshikawa
et al., 2009). As a result bacterial load is much lower compared to wild-type bacteria, providing an
explanation for the reduced ISG15 signal (Figure 2A). Taken together, our results reveal that ISG15
induction stems from cytosolic bacteria.
ISG15 is induced via the CSP following sensing of cytosolic DNA
In order to determine which pathway was essential for ISG15 induction, we performed an siRNA
screen of innate immune molecules that are known to be involved in bacterial sensing (Figure 2C). As
for the experiments described above, we used HeLa cells for the siRNA screen. Although HeLa cells
are reported to lack STING (Burdette and Vance, 2013), the ATCC line we worked with expressed
STING mRNA, as evidenced by qRT-PCR. We were able to specifically extinguish this signal with
siRNA (Figure 2—figure supplement 2). Our data showed that the ISG15 signal was clearly
dependent on IRF3, IRF7, STING, and TBK1, implicating the CSP. In further support of an interferon-
independent signal, depleting STAT1, which is a critical mediator of type I and III interferon signaling
did not abrogate the ISG15 signal (Figure 2C). In non-immune cells interferon induction has been
linked to sensing of triphosphorylated RNA by RIG-I (Abdullah et al., 2012; Hagmann et al., 2013);
however, in our experimental conditions, RIG-I did not seem to be required for the ISG15 signal.
Instead, it seems that direct ISG15 induction occurs through a pathway similar to the CSP in
macrophages.
We next sought which PAMP was necessary and sufficient for ISG15 induction. We transfected cells
with either Listeria genomic DNA, Listeria genomic DNA pre-treated with DNAse, Listeria total RNA,
or we permeabilized cells in the presence of cyclic-di-AMP. To control whether the cyclic di-AMP was
biologically active and reached the cytosol of the cells, we assessed IFNB1 levels by qRT-PCR
(Figure 2D). As expected Listeria cyclic di-AMP led to an increase in IFNB1 transcript levels. Although
IFNB1 induction with cyclic di-AMP was lower than that reported for murine macrophages
Figure 2. Continued
followed by Bonferonni’s multiple comparison test against transfection control. Statistical significance is indicated as follows: NS, nonsignificant; *p < 0.05;
**p < 0.01; ***p < 0.001.
DOI: 10.7554/eLife.06848.005
The following figure supplements are available for figure 2:
Figure supplement 1. Listeria ΔhlyΔplcAΔplcB does not escape the vacuole.
DOI: 10.7554/eLife.06848.006
Figure supplement 2. HeLa cells express STING mRNA.
DOI: 10.7554/eLife.06848.007
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(Woodward et al., 2010), it was similar to that reported for human phagocytes and monocytes
(Hansen et al., 2014). Listeria genomic DNA was the only PAMP sufficient for an increase in ISG15
levels (Figure 2E), whereas ISG15 levels following cytosolic exposure to cyclic-di-AMP did not
increase (Figure 2D). Collectively, these data implicate that the CSP can directly induce ISG15
after sensing of bacterial DNA in the cytosol of cells in a pathway that requires STING, TBK1, IRF3,
and IRF7.
ISG15 protects against Listeria infection in vitro and in vivo
We next assessed whether ISG15 has a functional effect on infection. We created a retroviral construct
that expresses an epitope-tagged version of ISG15 (3XFlag-6His-ISG15). We then infected cells that
stably express 3XFlag-6His-ISG15 with Listeria. As a control, cells were retrovirally transduced with
pBabe puro empty vector. For the same multiplicity of infection (MOI) after 3 hr of infection, stable
overexpression of ISG15 resulted in 50% fewer cytosolic bacteria as compared to control cells
(Figure 3A). We then assessed bacterial uptake by differentiating between the bacteria that are inside
the cell or those that remain on the surface (inside-out staining) and did not observe a difference
between control and ISG15-overexpressing cells for invasion (Figure 3—figure supplement 1A).
During a time course of infection in these cells at 7 and 12 hr, there were still 50% fewer bacteria, and
by 24 hr, the levels of bacteria had equalized between the two cell lines (Figure 3—figure
supplement 1B). This time course suggests that ISG15 does not impact bacterial replication as an
active bacterial clearance mechanism would (Figure 3—figure supplement 1B). We then knocked
down ISG15 during infection. This increased bacterial load by nearly twofold after 15 hr (Figure 3B,
Figure 3—figure supplement 2). These data strongly suggest that ISG15 plays a role in protection
against Listeria infection following uptake. To further explore this phenotype in primary cells, we
isolated mouse embryonic fibroblasts (MEFs) from wild-type and Isg15−/− embryos. We infected
these cells with Listeria and we observed a fivefold increase in bacterial load in Isg15−/− MEFs
compared to wild-type MEFs for the same MOI (Figure 3C,D). Interestingly, Isg15−/− MEFs are not
susceptible to other intracellular pathogens such as Shigella flexneri and Salmonella typhimurium,
and in HeLa cells only Staphylococcus aureus is able to induce as much ISG15 as Listeria
(Figure 3—figure supplement 1C,D). Indeed, S. flexneri and S. typhimurium induce very little
ISG15. We next examined whether ISG15 could also play a role during Listeria infection in vivo by
assessing the susceptibility of Isg15−/− animals to the pathogen during systemic infection (Osiak
et al., 2005). ISG15-deficient mice exhibited a significant increase in bacterial load compared to
wild-type animals in both the spleen and liver after 72 hr of systemic sub-lethal Listeria infection
(Figure 3E,F). Taken together, these data demonstrate that ISG15 restricts Listeria infection both in
vitro and in vivo.
ISGylation machinery is induced by Listeria and ISGylation protects
against infection
Since ISG15 can mediate its protective effect through conjugation-dependent or conjugation-
independent mechanisms, we wanted to determine if conjugation contributed to ISG15’s role in
defense against Listeria. Therefore, we initially assessed whether Listeria could induce the enzymes
required for ISGylation. To this end, we performed RNASeq of Lovo cells infected with Listeria for
24 hr compared to uninfected cells. The RNASeq data has been uploaded to Array Express with the
accession E-MTAB-3649 (Radoshevich et al., 2015b). We found that UBE1L (E1), UBE2L6 (E2), HERC5
and TRIM25 (E3s) mRNA are all significantly upregulated following Listeria infection, as is the
deconjugating enzyme USP18 (Figure 3G). In order to assess whether UBE2L6 and TRIM25 are
induced as rapidly as ISG15 at the protein level, we monitored their expression by immunoblot at 3 hr
post infection (Figure 3H). Interestingly, TRIM25 already displayed increased expression relative to
loading control at 3 hr post infection. UBE2L6 was present in these cells at this time point as well. We
then sought to determine whether conjugation-incompetent MEFs would have a higher bacterial load
following Listeria infection. Primary MEFs that lack UBE1L, and thus can not form ISG15 conjugates,
have a much higher bacterial burden following Listeria infection than wild-type MEFs at 4 hr post
infection. This phenotype mirrors the bacterial burden of Isg15−/− MEFs, clearly indicating that
ISG15’s role in host defense against Listeria in vitro requires ISGylation (Figure 3I).
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Figure 3. ISG15 protects against Listeria infection in vitro and in vivo. (A) Percentage of bacteria inside HeLa cells,
infected at an MOI of 25, which were transduced with empty vector (Control) or stably express ISG15 after 3 hr of
infection; CFUs of bacteria within control cells were normalized to 100%, data shown is AVG ± SEM. Statistical
significance were determined using two tailed t-test. (B) Percentage of bacteria inside HeLa cells which have been
transfected with siControl or siISG15 (15 hr of infection, MOI 25). siControl cells were normalized to 100%, data is
shown as AVG ± SEM. Statistical significance determined using two tailed t-test. (C) Primary mouse embryonic
fibroblasts (MEFs, Isg15+/+ or Isg15−/−) were infected with Listeria for 4 hr at an MOI of 10. CFUs of bacteria within
Isg15+/+ cells were normalized to 100%, and error bars represent ± SEM. Statistical significance determined using
two tailed t-test. (D) Data shown is average CFUs per ml ± SEM in Isg15+/+MEFs vs Isg15−/−MEFs following 4 hr of
infection, MOI 10. (E) and (F) Isg15+/+ or Isg15−/− mice were infected intravenously with 5 × 105 of Listeria strain
EGD. The liver and spleen were isolated following 72 hr of infection, and CFUs per organ were calculated by serial
dilution and replating; circles or squares depict individual animals. The line denotes AVG ± SEM. Significance for in
vivo data determined using Mann–Whitney test. (G) RNASeq data of significantly upregulated ISG15-related genes
compared with non-infected controls in LoVo cells following Listeria infection for 24 hr. (H) Cells were lysed and
Figure 3. continued on next page
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ISGylation modifies ER and Golgi proteins and increases canonical
secretion
Since ISG15 is a ubiquitin-like modifier that is known to be covalently linked to hundreds of cellular
and several viral substrates (Giannakopoulos et al., 2005; Zhao et al., 2005), our goal was to identify
which substrates following overexpression of ISG15 could account for the protective effect detected
in the context of Listeria infection and used a proteomic approach. We made use of SILAC coupled
with LC-MS/MS and compared cells that express empty vector, cells that express ISG15 and cells that
express ISG15 that were treated with interferon, the primary inducer of ISGylation (Figure 4A,B). We
identified thirty ISGylated proteins modified following overexpression of ISG15 (Figure 4C–E,
Figure 4—source data 1, depicted in blue). The proteomics data have been deposited to the
ProteomeXchange Consortium (Vizcaino et al., 2014) via the PRIDE partner repository with the data
set identifier PXD001805 (Radoshevich et al., 2015a). Interestingly, these proteins have not yet been
reported to be targets of ISGylation. Following interferon treatment, ISG15 modified twelve
additional proteins distinct from those that were ISGylated after overexpression without treatment
(Figure 4C–E, Figure 4—source data 1, depicted in red). Three of these proteins are known targets
of ISGylation following interferon treatment in the aforementioned screens. The other nine are novel
substrates of ISGylation. To gain more insight into the role of ISGylation of the modified substrates
following overexpression, we performed a gene ontology (GO) analysis of the thirty ISGylated
proteins. To our surprise over 80% of ISG15-target proteins are integral membrane proteins
(Figure 5A). Even more intriguingly they are known to be primarily localized to the endoplasmic
reticulum and Golgi apparatus and/or are critical for glycosylation, ER morphology and ER to Golgi
trafficking (e.g., the oligosaccharyl-transferase (OST) complex, RTN4, ATL3, SEC22B, ERGIC1, and
ERGIC3; Figure 4C). One of the proteins enriched following ISG15 overexpression is Magnesium
Transporter 1 (MAGT1). MAGT1 is critical for T cell activation and patients with a deletion in the
MAGT1 gene are susceptible to viral and certain bacterial infections (Li et al., 2014). The protein is
localized to the cell surface or to the ER where it interacts with the OST complex, which is critical for
N-glycosylation (Pfeffer et al., 2014). Notably, we also identified multiple proteins from the OST
complex as targets of ISGylation (Figure 4C, inset). To validate that MAGT1 was modified by ISG15,
we affinity purified ISGylated proteins and performed immunoblot analysis (Figure 5B). Two higher
molecular weight ISG15-MAGT1 complexes appear that are absent in control cells (Figure 5B,
arrows). To assess whether MAGT1 was ISGylated following infection, we immunoprecipitated ISG15
and could show that there is a higher molecular weight MAGT1 complex that immunoprecipitates
with ISG15 (Figure 5—figure supplement 1A). Additionally, non-conjugated MAGT1 was enriched
following ISG15 immunoprecipitation as well. Whether the interaction is direct or indirect within
a multi-protein complex remains to be determined. Of note, MAGT1 is also induced by Listeria
infection (Figure 5—figure supplement 1A). A second target of ISGylation following ISG15
overexpression is Reticulon 4 (RTN4) (Figure 4C,D). It is known that RTN4 helps to determine the
morphology of the endoplasmic reticulum (Voeltz et al., 2006). We also validated that endogenous
RTN4 was modified by ISG15 by immunoblot (Figure 5B), and we detected an upshifted ladder of
modified RTN4 that was also recognized by the ISG15 antibody. ISG15 is not known to make chains so
the ladder most likely corresponds to either multiple ISGylations of RTN4 or concomitant
modifications of RTN4 by ISG15 together with other modifiers as opposed to a single modification.
Figure 3. Continued
immunoblotted with the indicated antibodies following infection with Listeria for 3 hr. (I) Data shown is average
CFUs per ml ±SEM in Isg15+/+ MEFs vs Isg15−/− MEFs and in Ube1L+/+ and Ube1L−/− MEFs following 4 hr of
infection, using an MOI of 10. Statistical significance is indicated as follows: NS, nonsignificant; *p < 0.05; **p < 0.01;
***p < 0.001.
DOI: 10.7554/eLife.06848.008
The following figure supplements are available for figure 3:
Figure supplement 1. ISG15 protects cells from Listeria infection at early time points.
DOI: 10.7554/eLife.06848.009
Figure supplement 2. siRNA-mediated knockdown effectively depletes ISG15 during Listeria infection.
DOI: 10.7554/eLife.06848.010
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Here again we could validate the endogenous modification of RTN4 by ISG15 following Listeria
infection (Figure 5—figure supplement 1A) by detecting multiple distinct slower migrating bands of
RTN4 and ISG15 (Figure 5—figure supplement 1A). Interestingly, Atlastin-3, another protein that
affects ER morphology was also identified as an ISG15 target. We attempted to validate this
interaction by immunoblot but were unable to identify an upshifted complex, in part due to
inadequate antibody sensitivity (data not shown). Atlastin-3 is an ER dynamin-like GTPase that can
alter the morphology of both the ER and the Golgi apparatus (Rismanchi et al., 2008; Hu et al.,
2009). RTN4 and Atlastin-3 can interact to help shape the tubular ER. When RTN4 is overexpressed it
increases protein disulphide-isomerase (PDI) clustering in the cell (Yang et al., 2009; Bernardoni
et al., 2013). We thus assessed PDI puncta formation following ISG15 overexpression and in line
with our hypothesis found a dramatic increase in puncta formed upon ISG15 expression (Figure 5C).
Figure 4. Schematic representation of ISG15 targets identified by proteomics. (A) Epitope-tagged ISG15 (3XFLAG-6His-ISG15) represented binding to an
unknown target via isopeptide linkage. ISG15 has a stop codon engineered following the LRLRGG motif truncating the amino acid sequence which in
wild-type ISG15 would be removed by USP18 during maturation. (B) Scheme for enrichment of ISGylated targets using SILAC. Equal protein amounts of
each condition were combined, nickel affinity purified, and then analyzed by LC-MS/MS. (C) Scatter plot of Log2 transformed ISGylated proteins. The X
axis displays the medium (M) condition over light (L), which is ISG15 overexpression over empty vector control (in blue), and the Y axis displays the heavy
(H) condition over medium (M), which is interferon treatment over ISG15 expression (in red). Cut-off was determined as M/L ratio of greater than or equal
to one for ISG15 targets and H/M ratio of greater than or equal to one for interferon ISGylation targets. Inset is a representation of ISG15 targets from the
OST Complex. Other targets identified are proteins involved in ER morphology or ER to Golgi transport. (D) Representative MS spectra from ISG15, RTN4
and IFIT5 peptides: 100LTQTVAHLK108 from ISG15, 2+; 58KPAAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPR91 from RTN4, 3+ and 207AVTLNPDNSYIK218
from IFIT5, 2+. (E) Heat map of fold change of ISGylated proteins following ISG15 overexpression (in blue) and of ISGylated proteins following
interferon treatment (in red).
DOI: 10.7554/eLife.06848.011
The following source data is available for figure 4:
Source data 1. Enlarged heat map with protein identifiers related to Figure 4E.
DOI: 10.7554/eLife.06848.012
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Figure 5. ISGylation modifies ER and Golgi proteins and increases canonical secretion. (A) Gene ontology (GO)
analysis of ISGylated proteins enriched following ISG15 overexpression (blue) relative to all proteins identified in this
analysis (light gray) and all human proteins as annotated by the Uniprot/Swiss-prot database (dark gray). (B) Nickel
affinity purification of ISG15 in empty-vector control or ISG15 overexpression cells followed by α-ISG15, α-MAGT1,
and α-RTN4 immunoblot. Input is 0.1% of the initial affinity purification volume. Higher molecular weight species
corresponding to ISGylated RTN4 or MAGT1 are indicated. (C) Cells were fixed and immunostained with α-PDI
antibody (green), with α-TGN46 (red) and Hoechst (blue). Cells with four or more large puncta were enumerated as
cells with PDI clusters, a minimum of 100 cells were counted per experiment, and data are shown as percentage of
cells with PDI clusters; AVG ± SEM. Statistical significance determined using two-tailed t-test. (D) The indicated cells
were treated with 20 ng/ml TNF-α for 24 hr in a 96-well format. 100 μl of supernatant was collected for each ELISA
and assayed for the presence of IL-8 and IL-6. Statistical significance determined using two-tailed t-test. (E) The
indicated cells were infected for 3 or 7 hr with Listeria (MOI 25) in a 96-well format, supernatants were collected and
100 μl of supernatant was used for an IL-8 ELISA. Statistical significance determined using two-tailed t-test. (F) The
indicated cells were either infected with Listeria (MOI 25) for 24 hr in a 96-well format. 100 μl of supernatant was
collected for each ELISA and assayed for the presence of IL-6 or IL-8. Statistical significance determined using two-
tailed t-test. Statistical significance is indicated as follows: NS, nonsignificant; *p < 0.05; **p < 0.01; ***p < 0.001.
DOI: 10.7554/eLife.06848.013
The following figure supplements are available for figure 5:
Figure supplement 1. ISG15 covalently modifies RTN4 and MAGT1 following infection.
DOI: 10.7554/eLife.06848.014
Figure 5. continued on next page
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We further assessed the ERmorphology of ISG15-overexpressing cells by visualizing SEC61-GFP or KDEL-
BFP. Neither of these markers displayed an apparent redistribution in ISG15 overexpressing cells relative
to control cells (Figure 5—figure supplement 1B). We also assayed whether there was a difference in ER
mass using ER-tracker and FACS analysis (Figure 5—figure supplement 1C). There was no detectable
difference between the two cell lines in ER mean fluorescence intensity. Taken together, the most striking
effect of ISG15 overexpression on ER morphology is PDI clustering and distribution.
Certain UBL proteins, such as SUMO and ISG15, modify 1–5% of a given substrate; nevertheless,
this partial modification is sufficient to lead to a phenotypic effect on the substrate. We thus
investigated whether the enrichment of ER and Golgi proteins modified by ISG15 could have an effect
on the primary function of these organelles. Canonical secretion of cytokines and growth factors
involves translation and import of the proteins into the ER, folding and modification (e.g.,
glycosylation), within the ER, followed by sorting and trafficking within the Golgi culminating in
targeting to the plasma membrane. Since we found proteins implicated in many of these processes to
be ISGylated (Figure 4C), we thus hypothesized that canonical secretion could be altered in the
ISG15-overexpressing cells. As TNF-α is known to lead to canonical secretion of many cytokines, via
activation of NF-κB and MAPK pathways, we assessed secreted cytokine levels in ISG15-
overexpressing cells compared to control cells following TNF-α treatment. Among a panel of 31
human cytokines, we detected increased secretion of IL-8 and IL-6 in ISG15-expressing cells relative to
control cells (Figure 5—figure supplement 2). We validated these findings with quantitative ELISAs
for IL-6 and IL-8 (Figure 5D). ISG15-expressing cells secreted significantly more IL-6 and IL-8 following
TNF-α treatment than control cells (Figure 5D). As ISG15 itself has been reported to be able to act as
a secreted cytokine, we also assessed ISG15 in the supernatant. However, we did not observe
secreted ISG15 from either cell type (Figure 5—figure supplement 3).
Finally, based on the results observed following TNF-α treatment, it was of critical importance to
test whether a similar ISG15-dependent modulation of cytokine secretion occurred during Listeria
infection. As shown in Figure 5E, following infection, ISG15-overexpressing cells secreted significantly
more IL-8 than infected wild-type cells at both 3 and 7 hr post infection. The difference in IL-8
concentration in the media after 24 hr of infection was nearly threefold higher in ISG15-
overexpressing cells relative to control cells (Figure 5F). As with IL-8 the IL-6 concentration in the
media increased by threefold relative to control cells following 24 hr of infection. Moreover, we could
not detect ISG15 in the supernatant following infection in either cell line (Figure 5—figure
supplement 3). In order to confirm this effect on cytokine secretion under endogenous conditions, we
assayed whether ISG15 could modulate cytokine secretion following infection with L. monocytogenes
as opposed to L. innocua expressing InlB. Infection with L. monocytogenes led to significantly higher
IL-8 and IL-6 than L. innocua expressing InlB, which correlates with increased ISG15 expression
(Figure 5—figure supplement 1D). Furthermore, we assessed cytokine secretion in transformed
MEFs that lack ISG15, relative to their wild type counterparts following Listeria infection. Despite
significantly higher levels of bacteria in the Isg15−/− MEFs, the cells secreted significantly less IL-6
than wild-type cells (Figure 5—figure supplement 1E). Therefore, ISG15 appears to be a critical
modulator of cytokine secretion following Listeria infection. Collectively, our data reveal that during
Listeria infection ISG15 modification of distinct ER and Golgi proteins increases secretion of cytokines
which are known to counteract infection in vivo.
Discussion
ISG15 has primarily been characterized, in the context of infection, as an antiviral protein induced by
type I interferon. Here, we show for the first time, to our knowledge, that Listeria infection can lead to
Figure 5. Continued
Figure supplement 2. Non-biased assay of 31 cytokines following TNFα treatment in control vs ISG15-
overexpressing cells.
DOI: 10.7554/eLife.06848.015
Figure supplement 3. ISG15 is not secreted as a cytokine from HeLa cells following TNFα treatment or Listeria
infection.
DOI: 10.7554/eLife.06848.016
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the direct induction of an interferon-stimulated gene, ISG15, in a type I interferon-independent
manner in nonphagocytic cells. This induction requires STING, TBK1, IRF3 and IRF7 and Listeria DNA
is necessary and sufficient to induce the signal required to produce ISG15. We have demonstrated
that ISG15 restricts infection of nonphagocytic cells. Furthermore, primary fibroblasts that lack ISG15
or UBE1L are more susceptible to infection and animals deficient in ISG15 have a higher bacterial
burden both in the liver and spleen. Finally, our proteomic analysis has helped to reveal a novel
mechanism through which ISG15 and ISGylation can restrict Listeria infection. Furthermore, we
demonstrated a previously unidentified ISGylation of integral ER and Golgi proteins, which in turn
correlates with increased cytokine secretion upon infection.
Interferon-independent induction of ISG15 during Listeria infection
Listeria has long been used as a model organism to understand the adaptive immune response,
however more recently interest in the field has focused on the innate immune pathways required to
produce type I and type III interferons and bacterial modulators of type I and type III interferons
during Listeria infection of nonphagocytic cells (Lebreton et al., 2011; Abdullah et al., 2012; Bierne
et al., 2012; Hagmann et al., 2013; Odendall et al., 2014). In phagocytic cells, the primary type I
interferon response to Listeria is mediated by Listeria cyclic-di-AMP (Woodward et al., 2010). In
nonphagocytic cells, type I interferon is produced downstream of RIG-I sensing of triphosphorylated
RNA molecules (Abdullah et al., 2012; Hagmann et al., 2013). Here, we highlight a complementary
pathway, which can lead to rapid and direct interferon-independent induction of ISG15, and
potentially other ISGs, emanating from sensing of bacterial DNA. Notably, we implicate the same
molecular players required for the CSP in macrophages. However cyclic-di-AMP, the PAMP sensed by
the CSP in mouse macrophages, was not sufficient to directly induce ISG15 in an interferon-
independent manner in nonphagocytic cells. Interestingly, a similar pathway was implicated in sensing
the cytosolic bacterial DNA of Mycobacterium tuberculosis in macrophages (Manzanillo et al., 2012)
and sensing viral DNA in nonphagocytic cells (Hasan et al., 2013). Our study complements and
supports these findings as it also alludes to the importance of this response in nonphagocytic cells
during Listeria infection.
ISG15 as a novel modulator of canonical secretion
It is still an open question whether specific ISGs can contribute to a functional antibacterial state
similar to an antiviral state. We hypothesized that the massive induction of ISG15 following Listeria
infection must have a phenotypic effect on host cells. Indeed, we have demonstrated that ISG15
counteracts Listeria infection both in vitro and in vivo. The in vitro susceptibility is clearly conjugation-
dependent and we have preliminary data suggesting that the conjugation incompetent mutant of
ISG15 does not protect cells from infection (data not shown). During viral infections ISG15 can restrict
infection by direct modification of viral proteins (Zhao et al., 2010), by modification of host proteins
that are important to viral replication (Pincetic et al., 2010), by non-specific modification of newly
translated proteins to target viral capsid (Durfee et al., 2010) and finally in the context of infection in
vivo it can have non-conjugation dependent roles either within the cell or as a cytokine when secreted
from polymorphonuclear leukocytes (D’Cunha et al., 1996; Werneke et al., 2011; Bogunovic et al.,
2012). Here, we highlight a novel mode of action of ISG15 on canonical cytokine secretion that
correlates with modification of ER and Golgi proteins. Interestingly, ubiquitin itself can have an effect
on secretion by playing a role in determining COPII vesicle size and cargo through specific Cullin E3
ligases (Lu and Pfeffer, 2014). To our knowledge, a link between the intracellular function of ISG15
and canonical secretion of other cytokines has not been reported, thus our work identifies a novel
function of ISG15, which could also play a role in other bacterial and viral infections.
Two recent studies have underscored the importance of ISG15 in the human innate immune
response to pathogens by characterizing patients who lack a functional ISG15 protein (Bogunovic
et al., 2012; Zhang et al., 2014). ISG15-deficient patients were susceptible to Mycobacterium bovis
Bacille Calmette-Guérin (BCG). These individuals were shown to have reduced production of
interferon γ, which was linked to ISG15’s extracellular role as a cytokine. In light of our results, ISG15’s
intracellular role as a modulator of cytokine secretion in nonphagocytic cells could also be responsible
for reduced production of interferon γ.
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Role of cytokine secretion during Listeria infection in vivo
Increased cytokine secretion mediated by ISG15 is a previously uncharacterized way for the host to
engage the immune system to combat both bacterial and viral infection; the first cells that encounter
Listeria, (i.e., nonphagocytic cells) which are able to induce ISG15 at early time points could raise the alarm
against an invading pathogen and as a result help alert innate immune cells to the site of infection. In
particular, IL-6 and IL-8 are key mediators of neutrophil and monocyte recruitment in vivo and IL-6 has
been repeatedly characterized as a critical mediator of the innate immune response to Listeria (Baggiolini
and Clark-Lewis, 1992; Dalrymple et al., 1995; Personnic et al., 2010). If cytokine secretion in the
absence of ISG15 is less efficient, it could help to explain the moderate but statistically significant
susceptibility of Isg15−/−mice to systemic Listeria infection. These data coupled with the aforementioned
human ISG15-deficient patient susceptibility to BCG infection highlight the in vivo relevance of ISG15 as an
antibacterial factor (Bogunovic et al., 2012). Finally, the interferon-independent induction of ISG15 and
potentially other ISGs may help to explain the still perplexing phenotype of interferon receptor-deficient
mice (Ifnar−/−). IFNAR-deficient mice are highly resistant to Listeria infection when infected intravenously
(Auerbuch et al., 2004; Carrero et al., 2004; O’Connell et al., 2004; Stockinger et al., 2004). If certain
subsets of cells are in fact able to induce ISGs in the absence of interferon and if these ISGs like ISG15
could contribute to an antibacterial state, this may explain why these mice are resistant to Listeria infection.
Materials and methods
Materials
Dr Sandra Pellegrini (Institut Pasteur) kindly provided the 2fTGH and U5A (IFNAR2−/−) cell lines along with
an α-ISG15 antibody (gift from A Haas). Dr Matthew Albert and Dr Scott Werneke (Institut Pasteur)
generously provided the Ube1L−/− MEFs. Dr Gia Voeltz (University of Colorado) generously provided
SEC61-GFP and KDEL-BFP constructs. Dr Sabrina Jabs generously provided a plasmid expressing SV40
large T antigen. Full-length Listeria EF-Tu was used to generate α-EF-Tu antisera (Archambaud et al.,
2005). We used α-ISG15 antibodies from Abcam, UK (ISG15 3E5, ab48020), from Cell Signaling, Danvers,
Massachusetts (2743S) and from Santa Cruz, Dallas, Texas (ISG15 F-9, sc-166755). We used an α-Reticulon
4 antibody from Santa Cruz (RTN4 Nogo4 C-4, sc-271878) and an α-Atlastin-3 antibody from Millipore,
Billerica, Massachusetts (ABT20). We used α-TRIM25 (ab167154) and α-UBE2L6 (ab115524) antibodies
from Abcam. We used an α-ACTIN antibody from Sigma, Saint Louis, Missouri (AC-15, A5441). For
immunofluorescence, we used an α-TGN46 antibody from Abcam (ab50595), an α-PDI antibody from
Stressgen, Enzo Lifesciences, Farmingdale, New York (PDI (1D3) ADI-SPA-891-F) and an α-GM130
antibody from BD Transduction Laboratories, Franklin Lakes, New Jersey (610823). We used recombinant
B18R (34-8185-81) and ELISA kits for human IL-8 (88-8086-88), human IL-6 (88-7066-88) and mouse IL-6
(88-7064-88) from eBiosciences, San Diego, California. We used a human Pro-ISG15 ELISA kit from EMD
Millipore (CBA107) and a human cytokine array from Signosis, Sunnyvale, California (EA-4002).
Bacterial and mammalian growth conditions and infections
Bacterial strains used in this study are shown in Table 1. Mutant strains of Listeria generated for this
study were deleted from start to stop codon leaving intergenic regions intact (BUG3646, BUG3647,
and BUG3648). The triple mutant (LLO, PLCA, PLCB) was constructed sequentially starting from
a single mutant (as opposed to a deletion of the entire operon). Genes were deleted in Listeria strain
EGD-e prfA* (BUG 3057) by double recombination as previously described (Arnaud et al., 2004).
Listeria strains and S. aureus were grown in brain–heart infusion media (BD). S. typhimurium was
grown in Luria broth and S. flexneri in Tryptic Soy broth (BD). Prior to infection overnight cultures of
bacterial strains were diluted in new media and grown to exponential phase (OD 0.8 to 1), washed
three times in serum-free mammalian cell culture media and resuspended in mammalian cell culture
media at the indicated MOI. A fixed volume was then added to each well. Cells were centrifuged for
1 min at 1000 rpm to synchronize infection. The cells were then incubated with the bacteria for 1 hr at
37˚C, 10% CO2. Following this incubation, the cells were washed with room temperature 1× PBS and
cell growth medium with 10% serum was added with 20 μg/ml gentamicin to kill extracellular bacteria.
The cells were then harvested at the time point indicated in each figure.
HeLa cells (ATCC, CCL-2) were grown in MEM with Glutamax (Gibco, Waltham, Massachusetts)
supplemented with 10% fetal bovine serum, non-essential amino acids (Gibco) and sodium pyruvate
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(Gibco). 2fTGH cell lines and MEFs were grown in DMEM with 2 mM Glutamax supplemented with 10%
fetal bovine serum. When indicated primary MEFs were transformed with a plasmid expressing SV40 Large
T antigen (BUG 3790). Prior to infection, cells were seeded to attain 80% confluence on the day of infection.
In vivo infections
Female C57BL/6 mice (Isg15+/+ or Isg15−/−) were infected intravenously between 8 and 12 weeks of
age with 5 × 105 bacteria per animal and sacrificed 72 hr following infection. Colony forming units per
organ (liver or spleen) were enumerated after tissue dissociation and serial dilutions in sterile saline.
For the SDS-PAGE of animal samples, wild-type mice were infected intravenously with Listeria or
injected with sterile saline solution and sacrificed after 72 hr. The liver and spleen were isolated and
dissociated. Tissue homogenates were then centrifuged at 14,000 rpm for 10 min at 4˚C. For liver
tissue, an aliquot of the soluble fraction below the layer of fat was removed and resuspended in 2×
Laemmli buffer. For the spleen an aliquot of the supernatant was resuspended in 2× Laemmli buffer.
The samples were then run on an SDS-PAGE gel and blotted for ISG15 levels.
Ethics statement
This study was carried out in strict accordance with the French national and European laws and
conformed to the Council Directive on the approximation of laws, regulations and administrative
provisions of the Member States regarding the protection of animals used for experimental and other
scientific purposes (86/609/Eec). Experiments that relied on laboratory animals were performed in
strict accordance with the Institut Pasteur’s regulations for animal care and use protocol, which was
approved by the Animal experiment Committee of the Institut Pasteur (approval number n˚03–49).
SILAC and His-affinity purification
For SILAC labeling, DMEM without L-Lysine, L-Arginine, and L-Glutamine (Silantes, Germany) was
supplemented with 10% dialyzed serum (Invitrogen, Waltham, Massachusetts), 2 mM Glutamax
(Invitrogen) and naturally occurring L-Lysine HCl and L-Arginine HCl (K0R0, Light condition, Sigma),
4,4,5,5-D4-L-Lysine HCl and
13C6-L-Arginine HCl (K4,R6, Medium condition, Silantes) or
13C6,
15N2-L-
Lysine HCl and 13C6,
15N4-L-Arginine HCl (K8, R10, Heavy condition, Silantes). Lysine was added at its
normal concentration in DMEM (146 mg/l); however, arginine was added at 30% of its normal
concentration (25 mg/l) to prevent metabolic arginine to proline conversion. Stably transduced cell
lines were labeled for a minimum of seven passages in their respective medium prior to treatment.
Control cells (pBabe plasmid empty vector) were labeled light while Flag-His ISG15 ectopic
expression cells (pBabe-Flag-His ISG15 mature) were labeled medium or heavy.
Table 1. Bacterial strains used in this study
Bacterial species Strain
Listeria monocytogenes EGD BUG600
Listeria monocytogenes Δhly EGD BUG2132
Listeria monocytogenes ΔactA EGD BUG2140
Listeria innocua Clip11262 BUG499
Listeria innocua (InlB) Clip11262 BUG1642
Staphylococcus aureus SH1000
Salmonella typhimurium SR-11
Shigella flexneri M90T
Listeria monocytogenes EGD-e PrfA* BUG3057
Listeria monocytogenes ΔplcA EGD-e PrfA* BUG3646
Listeria monocytogenes Δhly EGD-e PrfA* BUG3647
Listeria monocytogenes Δhly ΔplcA
ΔplcB
EGD-e PrfA* BUG3648
Listeria monocytogenes EGD-e BUG1600
DOI: 10.7554/eLife.06848.017
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The nickel affinity purification was performed as described previously (Tatham et al., 2009), but
adapted for mass-spectrometry (Impens et al., 2014). We expanded the SILAC labeled cells to two large
500 cm2 per condition (approximately 10 × 107 cells per condition). We then treated the heavy-labeled
ISG15-expressing cells with type I interferon (interferon α2) at 1000 units per ml for 40 hr while the medium
and light-labeled cells were not treated. At 40 hr, post-treatment cells were lysed in 8 ml lysis buffer per
500-cm2 dish (6 M Guanidium-HCl, 10 mM Tris, 100 mM sodium phosphate buffer pH 8.0). The lysates
from two dishes were combined for each condition, sonicated and centrifuged. The pellet was discarded
and the protein concentration in the lysate was measured using a Bradford assay (Biorad, Hercules,
California). Equal protein amounts of each condition were mixed and proteins were reduced and alkylated
by incubation with 5 mM tris(2-carboxyethyl)phosphine (TCEP) and 10 mM chloroacetamide for 30 min at
37˚C in the dark. Excess chloroacetamide was quenched with 20 mM dithriothreitol prior to incubation of
the lysates overnight on a rotating wheel at 4˚C with 1 ml of packed NiNTA agarose beads that were pre-
equilibrated in lysis buffer (Qiagen, Netherlands). The following day, the agarose beads were washed once
in lysis buffer supplemented with 0.1% Triton X-100 and 5 mM β-mercaptoethanol. They were then
washed once in pH 8.0 wash buffer (8 M Urea, 10 mM Tris, 100 mM sodium phosphate buffer pH 8.0, 0.1%
Triton X-100, 5 mM β-mercaptoethanol), three times in pH 6.3 wash buffer (8 M Urea, 10 mM Tris, 100 mM
sodium phosphate buffer pH 6.3, 0.1% Triton X-100, 5 mM β-mercaptoethanol), and eluted in 1.5 ml 100
mM sodium phosphate buffer pH 6.8, 200 mM imidazole for 20 min at room temperature. The eluate
contained approximately 500 μg of protein and was further analyzed by LC-MS/MS.
LC-MS/MS
The eluate from the His-affinity purification was further diluted with 8.5 ml 50 mM ammonium
bicarbonate and proteins were digested with 20 μg trypsin overnight at 37˚C (Promega, Madison,
Wisconsin). Peptides were then purified on a Sep-Pak C18 cartridge (Waters, Milford, Massachusetts),
and 2 μg was injected for LC-MS/MS analysis on an Easy-nLC 1000 UHPLC system (Thermo Fisher
Scientific, Waltham, Massachusetts) in line connected to a Q Exactive mass spectrometer with
a NanoFlex source (Thermo Fisher Scientific). The sample was loaded on a reverse-phase column
(made in-house, 75 μm I.D. × 300 mm, 1.9 μm beads C18 Reprosil-Pur, Dr Maisch GmbH, Germany)
placed in a column oven (Sonation GmbH, Biberach, Germany) maintaining a constant temperature of
55˚C. Peptides were eluted by a linear increase from 5 to 28% acetonitrile in 0.1% formic acid over
130 min followed by a 55 min linear increase to 45% acetonitrile in 0.1% formic acid at a constant flow
rate of 250 nl/min. The mass spectrometer was operated in data-dependent mode, automatically
switching between MS and MS/MS acquisition for the 15 most abundant ion peaks per MS spectrum.
Full-scan MS spectra (300–1800 m/z) were acquired at a resolution of 70,000 after accumulation to
a target value of 1,000,000 with a maximum fill time of 120 ms. The 15 most intense ions above
a threshold value of 100,000 were isolated (window of 2.5 Th) for fragmentation by CID at
a normalized collision energy of 25% after filling the trap at a target value of 500,000 for maximum
120 ms with an underfill ratio of 2.5%. The S-lens RF level was set at 55, and we excluded precursor
ions with single, unassigned, and charge states above eight from fragmentation selection.
Data analysis was performed with MaxQuant (version 1.4.1.2) (Cox and Mann, 2008) using the
Andromeda search engine (Cox et al., 2011) with default search settings including a false discovery
rate set at 1% on both the peptide and protein level. Spectra were searched against the human
proteins in the Uniprot/Swiss-Prot database (database release version of January 2014 containing
20,272 human protein sequences, www.uniprot.org) with a mass tolerance for precursor and fragment
ions of 4.5 and 20 ppm, respectively, during the main search. To enable the identification of SILAC-
labeled peptides, the multiplicity was set to three with Lys4 and Arg6 settings in the medium channel
and Lys8 and Arg10 in the heavy channel, allowing for a maximum of 3 labeled amino acids per
peptide. Enzyme specificity was set as C-terminal to arginine and lysine, also allowing cleavage at
proline bonds and a maximum of three missed cleavages. Variable modifications were set to GlyGly
modification of lysine residues, oxidation of methionine residues, and pyroglutamate formation of
N-terminal glutamine residues. Carbamidomethyl formation of cysteine residues was set as a fixed
modification. In total, 692 proteins were quantified, and for each protein, the log2 values of the
normalized heavy/medium and normalized medium/light ratios were plotted against each other to
generate the scatter plot depicted in Figure 4, proteins listed in Figure 4E and Figure 4—source
data 1. Proteins with log2 medium/light ratios >1 were considered to be upregulated upon ISG15
Radoshevich et al. eLife 2015;4:e06848. DOI: 10.7554/eLife.06848 16 of 23
Research article Cell biology | Microbiology and infectious disease
expression, while proteins with log2 heavy/medium ratios >1 were classified to be upregulated after
interferon treatment. The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium (Vizcaino et al., 2014) via the PRIDE partner repository with the
dataset identifier PXD001805. GO terms enrichment analyses were performed using Database for
Annotation, Visualization and Integrated Discovery (DAVID) bioinformatics resources (Huang da
et al., 2009).
qRT-PCR, RNASeq, and SDS-PAGE
Total RNA was isolated using an RNAeasy kit (Qiagen). 1 μg of RNA from each condition was reverse
transcribed using the iScript cDNA synthesis kit (Biorad), and qRT-PCR was performed using SsoFast
EvaGreen supermix (Biorad) on a CFX384 Real-Time System with a C1000 Touch Cycler (Biorad). Data
were then analyzed using the ΔΔCT method relative to GAPDH levels for each sample.
For RNASeq uninfected LoVo cells were compared to LoVo cells infected with L. monocytogenes
strain EGD-e for 24 hr. The experiment was performed in triplicate, and total RNA following infection
was isolated using an RNeasy kit (Qiagen). Samples were subsequently checked for quality and sent to
Fasteris for library preparation and analysis. The RNASeq data has been uploaded to Array Express
with the accession E-MTAB-3649 (Radoshevich et al., 2015b; https://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-3649/) entitled ‘ISG15 counteracts Listeria monocytogenes infection’.
For SDS-PAGE analysis, samples were lysed following one wash in 1× PBS with 2× Laemmli buffer.
The cells were scraped in the sample buffer, resuspended and boiled at 95˚C for 5 min. Prior to
running the samples on a gel, they were sonicated two times for 8 s each to disrupt DNA. For SDS-
PAGE following a nickel-affinity purification, proteins were eluted with the following buffer (200 mM
imidazole, 5% SDS, 150 mM Tris-HCl pH 6.7, 30% glycerol, 720 mM β-mercaptoethanol, and 0.0025%
bromophenol blue). Gels were transferred using an iBLOT transfer system (Invitrogen), blocked in 5%
milk for 1 hr at RT, incubated with primary antibody overnight at 4˚C, washed with 0.1% Tween in 1×
PBS three times (each wash for 7 min), and incubated for an hour at room temperature with secondary
antibody coupled to HRP. Blots were washed again three times with 0.1% Tween in 1× PBS and
revealed using ECL-2 (Pierce, Waltham, Massachusetts).
Cloning, transfection, viral transduction, and permeabilization
Sandra Pellegrini provided us with a plasmid containing a 3XFlag-6His-tagged mature human ISG15 in
pCDNA3, which was a kind gift of Jon Huibregtse. This plasmid was used to clone a 3XFlag-6His-
ISG15 into pBabe-Puro (kindly provided by Jayanta Debnath) using BamHI and SalI (BUG3354).
Retroviral particles were then generated by co-transfection of viral GagPol MoMLV (BUG2666) and
VSV-G (BUG2667, both plasmids generously provided by Thierry Heidmann) and pBabe-puro 3xFlag-
6His-ISG15 in 293T cells. Cells were transfected using Fugene HD according to manufacturer’s
instructions (Promega). Supernatants were collected and applied to HeLa cells in the presence of
polybrene (Millipore) as described (in the protocol ‘Production of retroviruses using Fugene 6’ from
the Weinberg lab on Addgene). Cells were then selected using 2 μg/ml puromycin for 3 days. The
population of cells that survived puromycin treatment was expanded and tested for ISG15 expression.
For maintenance, cells were grown without puromycin and checked periodically for ISG15 expression.
In order to deliver Cyclic diAMP to the cytosol, cells were permeabilized with saponin according to the
protocol described in Johnson et al. (1996) with the indicated concentrations of Cyclic diAMP
(Biolog, Germany).
siRNA treatment
For siRNA treatment of cells, reverse transfection was used to minimize the siRNA concentration
required for knockdown. siGenome Smartpools (Dharmacon, Lafayette, Colorado) were resuspended
and aliquoted as per manufacturer’s instructions at a 20 μM concentration. Prior to transfection, stocks
were further diluted 1:2 with RNAase-free water, and 1.5 μl siRNA pool was added to 25 μl serum-free
media per well for a 24-well format. The final concentration per well was 60 nM. Equal volumes of
Lipofectamine RNAiMax (Invitrogen, 1.5 μl) were added to a second tube of 25 μl serum-free media,
and master mixes were made where possible to minimize pipetting error. After mixing the smart pool
tube with the RNAiMax tube and incubating for 15 min, 53 μl of mix was added to each well.
Subsequently, 450 μl of cell suspension was added to each well at a concentration of 222,000 cells/ml
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(100,000 cells per well). For larger scale knock down, the same concentrations were used but smart
pools, RNAiMax, and cell concentrations were scaled up accordingly. Since ISG15 is induced by
infection, we delivered siRNA during cell seeding and infected 24 hr later to make sure that the RNAi
complexes were still present in the cells while ISG15 was induced. For the siRNA screen, cells were
treated with siRNA pools for 72 hr and then infected with Listeria using the siControl condition as
a positive control for ISG15 induction and uninfected/untransfected cells as the baseline for normal
levels of ISG15 (since we show that nucleic acids alone can lead to ISG15 induction). Blots were
quantified using ImageJ relative to actin as a loading control.
Immunofluorescence, microscopy, and FACS
Cells were plated on coverslips the day prior to an experiment. Cells were fixed in 4% PFA (Electron
Microscopy Sciences, Hatfield, Pennsylvania) for 10 min at room temperature and permeabilized in
0.5% Triton X-100 (Sigma). Coverslips processed for immunofluorescence were mounted on
microscopy glass slides using Fluoromount G (Interchim, France), and images were acquired using
an inverted wide-field fluorescence microscope (AxioVert 200M, Carl Zeiss Microscopy, Germany)
equipped with an EMCCD Neo camera (Andor, Ireland) and the software MetaMorph (Molecular
Devices, Sunnyvale, California). FACS samples were labeled with 100 nM ER-Tracker Blue-White DPX
(Life Technologies) for 30 min, trypsinized, washed, and analyzed on a BD LSRFortessa.
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